Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology

Walter Huber1, Francis Mueller

  • 1F. Hoffmann-La Roche AG, Department of Pharma Research, CH-4070 Basel, Switzerland. walter.huber@roche.com

Summary

Surface Plasmon Resonance (SPR) technology analyzes biomolecular interactions for drug discovery. It provides real-time data on binding kinetics and thermodynamics, aiding in the development of improved drug candidates.